4.6 Article

Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation EVIDENCE FOR AN INTRACELLULAR ROUTE

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

PCSK9 as a therapeutic target of dyslipidemia

Nabil G. Seidah

EXPERT OPINION ON THERAPEUTIC TARGETS (2009)

Article Gastroenterology & Hepatology

PCSK9 Impedes Hepatitis C Virus Infection In Vitro and Modulates Liver CD81 Expression

Patrick Labonte et al.

HEPATOLOGY (2009)

Article Biochemistry & Molecular Biology

Structural and Biochemical Characterization of the Wild Type PCSK9-EGF(AB) Complex and Natural Familial Hypercholesterolemia Mutants

Matthew J. Bottomley et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells

Markey C. McNutt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice

Yi Luo et al.

JOURNAL OF LIPID RESEARCH (2009)

Article Multidisciplinary Sciences

A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates

Joyce C. Y. Chan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide

LiXin Shan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Biochemistry & Molecular Biology

Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels

Gaetan Mayer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Plasma PCSK9 preferentially reduces liver LDL receptors in mice

Aldo Grefhorst et al.

JOURNAL OF LIPID RESEARCH (2008)

Article Multidisciplinary Sciences

Molecular basis for LDL receptor recognition by PCSK9

Hyock Joo Kwon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor

Da-Wei Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Clathrin light chains function in mannose phosphate receptor trafficking via regulation of actin assembly

Viviane Poupon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Genetics & Heredity

Genetic heterogeneity of autosomal dominant hypercholesterolemia

M. Varret et al.

CLINICAL GENETICS (2008)

Article Medical Laboratory Technology

Serum proprotein convertase subtilisin Kexin type 9 is correlated directly with serum LDL cholesterol

William E. Alborn et al.

CLINICAL CHEMISTRY (2007)

Review Genetics & Heredity

The proprotein convertases are potential targets in the treatment of dyslipidemia

Nabil G. Seidah et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2007)

Article Biochemistry & Molecular Biology

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis

Yue-Wei Qian et al.

JOURNAL OF LIPID RESEARCH (2007)

Article Biochemistry & Molecular Biology

Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia

David Cunningham et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)

Article Medicine, Research & Experimental

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice

Thomas A. Lagace et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Cell Biology

Dynasore, a cell-permeable inhibitor of dynamin

Eric Macia et al.

DEVELOPMENTAL CELL (2006)

Article Biochemistry & Molecular Biology

Effect of mutations in the PCSK9 gene on the cell surface LDL receptors

J Cameron et al.

HUMAN MOLECULAR GENETICS (2006)

Article Multidisciplinary Sciences

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

S Rashid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment

KN Maxwell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Cardiac & Cardiovascular Systems

Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo

M Harada-Shiba et al.

CIRCULATION RESEARCH (2004)

Article Multidisciplinary Sciences

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

KN Maxwell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Genetics & Heredity

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

M Abifadel et al.

NATURE GENETICS (2003)

Article Multidisciplinary Sciences

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation

NG Seidah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)